| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | IDXX | Common Stock | 10 | 14 Feb 2022 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Award | +5,043 | 5,043 | 14 Feb 2022 | Common Stock | 5,043 | $505.53 | Direct | F2, F6 | |||
| transaction | IDXX | Incentive Stock Option (right-to-buy) | Award | +197 | 197 | 14 Feb 2022 | Common Stock | 197 | $505.53 | Direct | F3, F6 | |||
| transaction | IDXX | Restricted Stock Unit | Award | +593 | +801% | 667 | 14 Feb 2022 | Common Stock | 593 | Direct | F4, F6 | |||
| transaction | IDXX | Restricted Stock Unit | Award | +593 | +89% | 1,260 | 14 Feb 2022 | Common Stock | 593 | Direct | F5, F6 |
| Id | Content |
|---|---|
| F1 | Includes 10 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on December 31, 2021. |
| F2 | Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2023. |
| F3 | Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant. |
| F4 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. |
| F5 | Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in one installment on February 14, 2025. |
| F6 | Not applicable. |